Literature DB >> 30274827

ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinol.

Lisa K Stamp1, Mary Wallace2, Rebecca L Roberts2, Christopher Frampton3, Jeffrey N Miner4, Tony R Merriman5, Nicola Dalbeth6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30274827     DOI： 10.1016/j.dmpk.2018.09.002

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN： 1347-4367            Impact factor:   3.614


× No keyword cloud information.
  4 in total

1.  Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration.

Authors:  Lisa K Stamp; Peter T Chapman; Murray Barclay; Anne Horne; Christopher Frampton; Tony R Merriman; Daniel F B Wright; Jill Drake; Nicola Dalbeth
Journal:  Clin Transl Sci       Date:  2019-09-03       Impact factor: 4.689

2.  An association study of ABCG2 rs2231142 on the concentrations of allopurinol and its metabolites.

Authors:  Marc-Olivier Pilon; Grégoire Leclair; Essaïd Oussaïd; Isabelle St-Jean; Martin Jutras; Marie-Josée Gaulin; Ian Mongrain; David Busseuil; Jean Lucien Rouleau; Jean-Claude Tardif; Marie-Pierre Dubé; Simon de Denus
Journal:  Clin Transl Sci       Date:  2022-06-10       Impact factor: 4.438

3.  The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion.

Authors:  Kazi Mirajul Hoque; Eryn E Dixon; Raychel M Lewis; Jordyn Allan; Gregory D Gamble; Amanda J Phipps-Green; Victoria L Halperin Kuhns; Anne M Horne; Lisa K Stamp; Tony R Merriman; Nicola Dalbeth; Owen M Woodward
Journal:  Nat Commun       Date:  2020-06-02       Impact factor: 14.919

Review 4.  Medically Important Alterations in Transport Function and Trafficking of ABCG2.

Authors:  László Homolya
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.